These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 27160704)

  • 41. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network.
    Golipour A; David L; Liu Y; Jayakumaran G; Hirsch CL; Trcka D; Wrana JL
    Cell Stem Cell; 2012 Dec; 11(6):769-82. PubMed ID: 23217423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
    Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
    Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells.
    de Lázaro I; Bussy C; Yilmazer A; Jackson MS; Humphreys NE; Kostarelos K
    Biomaterials; 2014 Sep; 35(29):8312-20. PubMed ID: 25002261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation.
    Miyamoto T; Furusawa C; Kaneko K
    PLoS Comput Biol; 2015 Aug; 11(8):e1004476. PubMed ID: 26308610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive proteogenomic analysis of human embryonic and induced pluripotent stem cells.
    Parrotta EI; Scalise S; Taverna D; De Angelis MT; Sarro G; Gaspari M; Santamaria G; Cuda G
    J Cell Mol Med; 2019 Aug; 23(8):5440-5453. PubMed ID: 31237115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells.
    Bharathan SP; Manian KV; Aalam SM; Palani D; Deshpande PA; Pratheesh MD; Srivastava A; Velayudhan SR
    Biol Open; 2017 Jan; 6(1):100-108. PubMed ID: 28089995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
    Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
    Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
    Anokye-Danso F
    Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The oncogene c-Jun impedes somatic cell reprogramming.
    Liu J; Han Q; Peng T; Peng M; Wei B; Li D; Wang X; Yu S; Yang J; Cao S; Huang K; Hutchins AP; Liu H; Kuang J; Zhou Z; Chen J; Wu H; Guo L; Chen Y; Chen Y; Li X; Wu H; Liao B; He W; Song H; Yao H; Pan G; Chen J; Pei D
    Nat Cell Biol; 2015 Jul; 17(7):856-67. PubMed ID: 26098572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.
    Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S
    BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Shared gene regulation during human somatic cell reprogramming.
    Wang X; Chen X; Zhang H; Qin W; Xue Y; Zeng F
    J Genet Genomics; 2012 Dec; 39(12):613-23. PubMed ID: 23273765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Derivation of stable embryonic stem cell-like, but transcriptionally heterogenous, induced pluripotent stem cells from non-permissive mouse strains.
    Garbutt TA; Konganti K; Konneker T; Hillhouse A; Phelps D; Jones A; Aylor D; Threadgill DW
    Mamm Genome; 2020 Dec; 31(9-12):263-286. PubMed ID: 33015751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells.
    Manian KV; Aalam SM; Bharathan SP; Srivastava A; Velayudhan SR
    Cell Reprogram; 2015 Dec; 17(6):427-40. PubMed ID: 26562626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.
    Yuan X; Wan H; Zhao X; Zhu S; Zhou Q; Ding S
    Stem Cells; 2011 Mar; 29(3):549-53. PubMed ID: 21425417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells.
    Ji H; Zhang X; Oh S; Mayhew CN; Ulm A; Somineni HK; Ericksen M; Wells JM; Khurana Hershey GK
    J Allergy Clin Immunol; 2015 Jan; 135(1):236-44. PubMed ID: 25441642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
    Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells.
    Loewer S; Cabili MN; Guttman M; Loh YH; Thomas K; Park IH; Garber M; Curran M; Onder T; Agarwal S; Manos PD; Datta S; Lander ES; Schlaeger TM; Daley GQ; Rinn JL
    Nat Genet; 2010 Dec; 42(12):1113-7. PubMed ID: 21057500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excessive Cellular Proliferation Negatively Impacts Reprogramming Efficiency of Human Fibroblasts.
    Gupta MK; Teo AK; Rao TN; Bhatt S; Kleinridders A; Shirakawa J; Takatani T; Hu J; De Jesus DF; Windmueller R; Wagers AJ; Kulkarni RN
    Stem Cells Transl Med; 2015 Oct; 4(10):1101-8. PubMed ID: 26253715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
    Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
    Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.